Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001306550-23-007069
Filing Date
2023-02-03
Accepted
2023-02-03 12:10:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 us09075p1057_020323.txt SC 13G 11581
  Complete submission text file 0001306550-23-007069.txt   13280
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90437 | Film No.: 23584693
SIC: 2834 Pharmaceutical Preparations